NEW YORK, Aug. 6 - Quark Biotech and Japanese pharma firm Fujisawa today said they have penned a drug-discovery collaboration to treat stroke.

Terms of the deal call for Fujisawa to fund the research program, in which Quark will use its high-throughput technology.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.